Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Wall Street week ahead: Spotlight on Federal Reserve rate decision, retail sales, Middle East, G7 summit
Market participants will be looking for signals on how the new Fed chief Kevin Warsh intends to tackle lingering inflation concerns while balancing economic growth
Global air travel demand to slow to 2.1% in 2026, IATA says
Global air travel demand is set to grow in 2026, but at a slower rate. The Middle East faces a significant contraction due to ongoing conflicts. Africa is projected for the strongest growth. Asia Pacific will lead global expansion. Europe and Latin America will see moderate increases. North America's growth will be limited. The industry shows adaptability despite challenges.
Goldman Sachs, Morgan Stanley and others buy stake in Rs 1,960 crore Lenskart block deal
ADIA-backed Platinum Jasmine A 2018 Trust sold a 2.3% stake in Lenskart through a Rs 1,960 crore block deal. The transaction attracted strong participation from mutual funds, insurers and foreign investors, reflecting continued confidence in the eyewear retailer’s growth prospects.
Zee Entertainment plans to raise at least ₹2,300 crore for future growth
ZEEL board approves plan to raise at least 2300 crore in phases to fund strategic and business initiatives, including expansion after securing FIFA broadcasting rights
ICICI Prudential Mutual Fund raises stake in Travel Food Services, shares rise
ICICI Prudential Mutual Fund has announced the acquisition of an additional stake in Travel Food Services, increasing its total shareholding in the company to above 5%.
Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.
SBI in $1 billion funding for Sun Pharma’s US deal
State Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co. This move marks a significant step for government-run banks in financing corporate takeovers. SBI will join other global lenders in this substantial deal. The funding underscores the growing ambition of Indian companies to expand globally.
INR stays pressured amid elevated oil prices and firm dollar overseas
The Indian rupee is staying largely unchanged in opening trades on Tuesday amid elevated oil prices and relatively firm dollar overseas. INR opened at Rs 95.47 per dollar and hit a low of 95.62 so far during the day. Yesterday, rupee lost further momentum and settled the day lower by around 40 paise at Rs 95.61 per dollar. Dollar index spiked above 100 for the first time in two months following a strong jobs data on Friday, driving sooner than expected rate hike by Fed but has edged marginally below the level today. Meanwhile, Indian shares fell sharply on Monday, mirroring weak cues from global markets as Middle East worries persisted and robust U.S. jobs data led traders to ramp up bets on a Federal Reserve rate hike this year. The BSE Sensex and NSE Nifty 50 settled lower amid weak global cues, escalating tensions in West Asia, and rising crude oil prices. The Sensex dropped 719.08 points (0.97%) to settle at 73,524.26, while the Nifty fell 243.70 points (1.04%) to end the day at .
INR dragged lower by negative cues from equities, surging oil and firm dollar overseas
The Indian rupee lost further momentum during the course of the day and is seen settling the day lower by around 40 paise at Rs 95.57 per dollar. Elevated crude oil prices and firm dollar index around 100 mark are seen pressurizing rupee. Dollar index spiked above 100 for the first time in two months following a strong jobs data on Friday, driving sooner than expected rate hike by Fed but has edged marginally below the level today. Meanwhile, Indian shares fell sharply on Monday, mirroring weak cues from global markets as Middle East worries persisted and robust U.S. jobs data led traders to ramp up bets on a Federal Reserve rate hike this year. The BSE Sensex and NSE Nifty 50 settled lower amid weak global cues, escalating tensions in West Asia, and rising crude oil prices. The Sensex dropped 719.08 points (0.97%) to settle at 73,524.26, while the Nifty fell 243.70 points (1.04%) to end the day at 23,123.00. Also, rupee weakened despite the Indian government introducing a ...
Global Capital Is Chasing AI Giants, But India Remains a Stock Picker's Market, Says Hiren Ved
The veteran fund manager noted that while the Nifty has largely moved sideways over the past two years, several stocks have generated substantial returns during the same period.
Peak XV sells stake in Go Digit to JP Morgan, Aditya Birla MF for ₹100 cr
JP Morgan and Aditya Birla Sun Life Mutual Fund have collectively acquired over 33.3 lakh shares of Go Digit General Insurance from Peak XV Partners for Rs 100 crore through open market transactions. Following the transaction, shares of Go Digit General Insurance on Friday rose 5 per cent to Rs 318 apiece on the National Stock Exchange (NSE). US-based JP Morgan through its affiliate JP Morgan (Taiwan) Eastern Technology Fund and Aditya Birla Sun Life Mutual Fund purchased 33,33,500 shares representing nearly a 0.4 per cent stake in Bengaluru-based Go Digit General Insurance, according to the block deal data executed on Thursday on the exchange. The shares were acquired at an average price of Rs 300 apiece, taking the combined deal value to Rs 100 crore. Meanwhile, venture capital firm Peak XV Partners through its arm Peak XV Partners Growth Investments III offloaded the same number of shares in the transaction, as per the data. The stake sale comes after Peak XV Partners fully exi